Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongfeng Qu

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Current Pharmacology Reports|September 15, 2015
Regulation of miRNAs by agents targeting the tumor stem cell markers DCLK1, MSI1, LGR5, and BMI1Sripathi M Sureban, Dongfeng Qu, Courtney W Houchen
The American Journal of Pathology|May 1, 2012
Epigenetic variants and biomarkers for colon cancerDongfeng Qu, Sripathi M Sureban, Courtney W Houchen
Expert Opinion on Therapeutic Targets|November 12, 2020
Tuft cells: an emerging therapeutic target for pancreatitis and pancreatic cancer?Yuning Yang, Ling Ding, Zhiyun Cao, et al.
Cancers|January 26, 2020
Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma MicroenvironmentsXiangyan Wu, Dongfeng Qu, Nathaniel Weygant, et al.
Cancers|December 22, 2020
Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor MicroenvironmentZhiyun Cao, Nathaniel Weygant, Parthasarathy Chandrakesan, et al.
The Journal of Biological Chemistry|May 30, 2002
The crystal structure of the endothelial protein C receptor and a bound phospholipidVaheh Oganesyan, Natalia Oganesyan, Simon Terzyan, et al.
Blood|October 7, 2006
Effects of membrane and soluble EPCR on the hemostatic balance and endotoxemia in miceXunzhen Zheng, Weihong Li, Jian-Ming Gu, et al.
Research Square|March 31, 2025
A Novel D-peptide modulates DCLK1 Gelsolin interactions, reducing PDAC tumor growthLandon L Moore, Dongfeng Qu, Parthasarathy Chandrekesan, et al.
Scientific Reports|October 14, 2025
A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growthLandon L Moore, Dongfeng Qu, Parthasarathy Chandrekesan, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 26, 2013
Inhibition of Notch signaling reduces the number of surviving Dclk1+ reserve crypt epithelial stem cells following radiation injuryDongfeng Qu, Randal May, Sripathi M Sureban, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Current Pharmacology Reports|September 15, 2015
Regulation of miRNAs by agents targeting the tumor stem cell markers DCLK1, MSI1, LGR5, and BMI1Sripathi M Sureban, Dongfeng Qu, Courtney W Houchen
The American Journal of Pathology|May 1, 2012
Epigenetic variants and biomarkers for colon cancerDongfeng Qu, Sripathi M Sureban, Courtney W Houchen
Expert Opinion on Therapeutic Targets|November 12, 2020
Tuft cells: an emerging therapeutic target for pancreatitis and pancreatic cancer?Yuning Yang, Ling Ding, Zhiyun Cao, et al.
Cancers|January 26, 2020
Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma MicroenvironmentsXiangyan Wu, Dongfeng Qu, Nathaniel Weygant, et al.
Cancers|December 22, 2020
Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor MicroenvironmentZhiyun Cao, Nathaniel Weygant, Parthasarathy Chandrakesan, et al.
The Journal of Biological Chemistry|May 30, 2002
The crystal structure of the endothelial protein C receptor and a bound phospholipidVaheh Oganesyan, Natalia Oganesyan, Simon Terzyan, et al.
Blood|October 7, 2006
Effects of membrane and soluble EPCR on the hemostatic balance and endotoxemia in miceXunzhen Zheng, Weihong Li, Jian-Ming Gu, et al.
Research Square|March 31, 2025
A Novel D-peptide modulates DCLK1 Gelsolin interactions, reducing PDAC tumor growthLandon L Moore, Dongfeng Qu, Parthasarathy Chandrekesan, et al.
Scientific Reports|October 14, 2025
A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growthLandon L Moore, Dongfeng Qu, Parthasarathy Chandrekesan, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 26, 2013
Inhibition of Notch signaling reduces the number of surviving Dclk1+ reserve crypt epithelial stem cells following radiation injuryDongfeng Qu, Randal May, Sripathi M Sureban, et al.
Pageof 5